MedTrace Logo

Global Performance Evaluation of the AMS CONTINUUM™ Device

NCT01083199 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-04-12

Study results available
· View outcomes & findings →

Summary

1. To evaluate Device performance in providing mucosa to mucosa apposition to facilitate sustainable vesico-urethral anastomosis during a radical prostatectomy procedure.
2. To assess clinical outcomes of the Device in facilitating the vesico-urethral anastomosis following a radical prostatectomy.

Conditions

Interventions

DEVICE

CONTINUUM™

Performance of CONTINUUM™ in facilitating the vesico-urethral anastomosis following radical prostatectomy.

Sponsors & Collaborators

  • American Medical Systems

    lead INDUSTRY

Principal Investigators

  • Evangelos Liatsikos, MD · University of Patras

  • Carlos Hernandez, MD · Hospital University Gregorio Maranon

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Greece
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083199 on ClinicalTrials.gov